Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
Clinical trial NCT06450314 · RECRUITING
Trial details
- NCT number
- NCT06450314
- Sponsor
- UNICANCER
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-25
- Primary completion
- 2027-12-15
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.